Washington, U.S. | Xinhua | The U.S. Food and Drug Administration (FDA) on Thursday authorized American pharmaceutical company Merck’s oral antiviral for the treatment of mild-to-moderate COVID-19, the second pill approved for treating COVID-19 following the one from Pfizer. Merck’s pill, called molnupiravir, is authorized to use in adults with positive results of direct SARS-CoV-2 viral …
The post U.S. FDA okays emergency use of molnupiravir pill for COVID-19 appeared first on The Independent Uganda:.
